Details for Patent: 9,132,110
✉ Email this page to a colleague
Which drugs does patent 9,132,110 protect, and when does it expire?
Patent 9,132,110 protects PENNSAID and is included in one NDA.
Summary for Patent: 9,132,110
Title: | Treatment of pain with topical diclofenac |
Abstract: | The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. |
Inventor(s): | Singh; Jagat (Scarborough, CA), Shainhouse; Joseph Zev (North York, CA), Galer; Bradley S. (West Chester, PA), King-Smith; Robert Dominic (San Diego, CA), Grierson; Lisa Marie (Richmond Hill, CA), Burian; Maria (Stolberg, DE), Wilkin; Jonathan (Columbus, OH), Kisak; Edward (San Diego, CA), Newsam; John M. (La Jolla, CA) |
Assignee: | HZNP LIMITED (Pembroke, BM) |
Application Number: | 13/665,790 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,132,110 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,132,110
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Horizon | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623-001 | Jan 16, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | USE OF TOPICAL DICLOFENAC FOR TREATING PAIN | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |